UK trial confirms validity of neonatal extracorporeal membrane oxygenation (ECMO)
This article was originally published in Clinica
A collaborative UK trial has found that 68% of neonates receiving extracorporeal membrane oxygenation (ECMO) for severe but reversible respiratory failure survive. The 55 hospitals participating in a three-year nationwide randomised study of 185 infants found that this compares with a 41% survival rate following conventional care procedures, reports The Lancet (July 13th).
You may also be interested in...
Trump administration effort to reduce drug prices by curtailing agency program requiring new approvals for some old products undermines FDA’s role in policing the safety of prescription drugs, experts say.
The maker of prestige-inspired cosmetics at value prices follows its TikTok viral success by teaming with Kathleen Belsten, aka Loserfruit, the second most-followed female gamer on the Amazon-owned livestreaming platform Twitch.
As distribution of Regeneron’s monoclonal antibody treatment for coronavirus begins, OWS officials worry about provider confusion with Lilly’s product due to differences in preparation and administration.